Treatment
Junctional Tachycardia
Table 17. Acute Treatment of Junctional Tachycardia
COR
LOE Recommendations
IIa C-LD IV beta blockers are reasonable for acute treatment in patients
with symptomatic junctional tachycardia.
IIa C-LD IV diltiazem, procainamide, or verapamil is reasonable for acute
treatment in patients with junctional tachycardia.
Table 18. Ongoing Management of Junctional Tachycardia
COR
LOE Recommendations
IIa C-LD Oral beta blockers are reasonable for ongoing management in
patients with junctional tachycardia.
IIa C-LD Oral diltiazem or verapamil is reasonable for ongoing
management in patients with junctional tachycardia.
IIb C-LD Flecainide or propafenone may be reasonable for ongoing
management in patients without SHD or ischemic heart disease
who have junctional tachycardia.
IIb C-LD Catheter ablation may be reasonable in patients with
junctional tachycardia when medical therapy is not effective or
contraindicated.
Figure 12. Ongoing Management of Junctional Tachycardia
Junctional tachycardia
Beta blockers, diltiazem,
or verapamil
(Class IIa)
Flecainide or propafenone
(in the absence of SHD)
(Class IIb)
Drug therapy options
Catheter ablation
(Class IIb)
If ineffective or
contraindicated
24
